*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Enhancement of the diagnosis and treatment of early rheumatoid arthritis

Author: MAKTUBA TASHPULATOVA, ZAFAR SHARAPOV, MAKHSUMA SULTANOVA, FERUZA ZIYAYEVA, MASUDA KASIMOVA
Abstract: The early stage of RA is strategically essential for treatment and at the same time, the most difficult for diagnosis. It is characterized by the prevalence of exudative changes in affected joints, frequent atypical flow and good response to treatment. If active treatment is administered at a very early stage, remission can be achieved in 6 months among 47% of patients and a year later, among 58.1% of patients. Prescription of combined baseline therapy in RA reduces the severity of clinical manifestations in "early" RA, improves functional activity and slows down the radiological progression of joint damage, improves the quality of life and reduces the risk of disability, reduces mortality in RA to a population level.
Keyword: early rheumatoid arthritis, diagnostics, treatment, basic anti-inflammatory drugs, combined therapy.
DOI: https://doi.org/10.31838/ijpr/2020.12.02.225
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free